Page last updated: 2024-11-05

2,3,4,5,6-pentafluorophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3,4,5,6-pentafluorophenol: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13041
SCHEMBL ID34203
MeSH IDM0226965

Synonyms (53)

Synonym
a2ycf0yuha ,
phenol, 2,3,4,5,6-pentafluoro-
unii-a2ycf0yuha
BB 0260207
nsc21627
nsc-21627
phenol, pentafluoro-
pentafluorophenol
771-61-9
nsc 21627
2,3,4,5,6-pentafluorophenol
einecs 212-235-8
pentafluorophenol, analytical standard
pentafluorophenol, reagentplus(r), >=99%
xbngyffabrkick-uhfffaoysa-
inchi=1/c6hf5o/c7-1-2(8)4(10)6(12)5(11)3(1)9/h12h
AKOS005063543
P0919
perfluorophenol
A838985
2,3,4,5,6-pentakis(fluoranyl)phenol
2,3,4,5,6-pentafluoro-phenol
2,3,4,5,6-pentafluorohydroxybenzene
c6hf5o
BP-20438
FT-0632927
STL371305
BBL027372
SCHEMBL34203
pentafluorophenol [mi]
hydroxypentafluorobenzene
pentafluorohydroxybenzene
pentafluoro-phenol
pentafluoro phenol
c6f5oh
DTXSID9061120
Q-201543
mfcd00002156
CS-W008591
Z275118756
hopfp
pentafluorophenol, vetec(tm) reagent grade, 98%
SY012977
F0001-1984
BCP18149
AS-13520
qfz ,
AMY8656
Q27273543
A929407
P10006
PB47332
HY-I0865

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Methods using aqueous acetonitrile gradients on each of two commercial PFP columns were developed that are suitable for the determination of potency, content uniformity, and degradation profile of the paclitaxel bulk drug and injectable dosage form."( Determination of paclitaxel and related taxanes in bulk drug and injectable dosage forms by reversed phase liquid chromatography.
Locke, DC; Shao, LK, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (5.71)18.2507
2000's9 (25.71)29.6817
2010's19 (54.29)24.3611
2020's5 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.84 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]